CAR T Cells: Expanding into Multiple Myeloma

Results from two early-phase trials presented at the American Society of Clinical Oncology suggest that an immunotherapy using genetically engineered immune cells may be effective in patients with advanced multiple myeloma.

http://ift.tt/2sjYS0K